The digital health landscape is undergoing a significant transformation, marked by a contraction in investment and a shift towards consolidation in Australia and globally. A recent report from Galen Growth indicates that venture capital funding for digital health dropped to $7.1 billion across 216 deals in Q1 2026, reflecting a 6.6% year-on-year decline. This trend is characterized by fewer but larger investments, with the average deal size increasing by 87% to $38.4 million.
Emma Hossack, CEO of the Medical Software Industry Association, noted that the market is evolving towards a more realistic approach where established technologies with proven results are prioritized over novel ideas lacking sustainability. This shift is indicative of a growing recognition that health systems are crucial in determining the success of health tech initiatives, as they now act as "kingmakers" in the sector.
Consolidation is also accelerating, with a notable 46 mergers and acquisitions in a single quarter, signaling a preference for integrated platforms that align closely with clinical workflows. The report highlights that health systems, rather than venture capital, are driving much of this consolidation, emphasizing the need for digital solutions to demonstrate clear clinical and economic value.
This maturation of the digital health sector suggests that companies focusing on specific clinical workflows and delivering measurable outcomes will be more successful. As regulatory demands increase for clinical validation and cost-effectiveness, the landscape will likely continue to favor those who can navigate the complexities of healthcare procurement and reimbursement effectively.